Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
暂无分享,去创建一个
E. Génin | D. Hervé | I. Callebaut | E. Tournier-Lasserve | Lucile Broseus | M. Kraemer | F. Bergametti | M. Kossorotoff | J. Schwitalla | Stéphanie Guey | Thomas E. Ludwig | Simone Choi | Lucile Broseus
[1] E. Merello,et al. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. , 2020, Journal of neurosurgical sciences.
[2] G. Rouleau,et al. RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population. , 2016, American journal of human genetics.
[3] S. Miyamoto,et al. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[4] M. Brozman,et al. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients , 2016, PloS one.
[5] Michael J Bamshad,et al. Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project. , 2016, American journal of human genetics.
[6] K. Kosaki,et al. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy , 2016, American journal of medical genetics. Part A.
[7] Eun Jung Koh,et al. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1. , 2016, Journal of neurosurgery. Pediatrics.
[8] H. Augustin,et al. Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling. , 2016, Developmental cell.
[9] C. Adamsbaum,et al. Early-onset stroke with moyamoya-like syndrome and extraneurological signs: a first reported paediatric series , 2016, European Radiology.
[10] A. Koizumi,et al. A new horizon of moyamoya disease and associated health risks explored through RNF213 , 2015, Environmental Health and Preventive Medicine.
[11] J. Belmont,et al. Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant , 2015, American journal of medical genetics. Part A.
[12] Alexander A. Morgan,et al. Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing , 2015, G3: Genes, Genomes, Genetics.
[13] M. Lathrop,et al. Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia , 2015, Journal of hypertension.
[14] Kai Wang,et al. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan , 2015, Journal of the Neurological Sciences.
[15] Iuliana Ionita-Laza,et al. Empirical Bayes scan statistics for detecting clusters of disease risk variants in genetic studies , 2015, Biometrics.
[16] Michael J E Sternberg,et al. The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.
[17] T. Nariai,et al. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease , 2015, Journal of the American Heart Association.
[18] D. Hervé,et al. The Application of Clinical Genetics Dovepress Moyamoya Disease and Syndromes: from Genetics to Clinical Management , 2022 .
[19] J. Pruneda,et al. Allosteric Activation of the RNF146 Ubiquitin Ligase by a Poly(ADP-ribosyl)ation Signal , 2014, Nature.
[20] T. Nariai,et al. Systematic Validation of RNF 213 Coding Variants in Japanese Patients With Moyamoya Disease , 2015 .
[21] Gao T. Wang,et al. RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.
[22] Katherine R. Smith,et al. Identification of a Novel RNF213 Variant in a Family with Heterogeneous Intracerebral Vasculopathy , 2014, International journal of stroke : official journal of the International Stroke Society.
[23] G. Abecasis,et al. Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.
[24] J. Hoseki,et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state , 2014, Scientific Reports.
[25] J. Pruneda,et al. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. , 2014, Biochimica et biophysica acta.
[26] A. Koizumi,et al. Genomewide association study identifies no major founder variant in Caucasian moyamoya disease , 2013, Journal of Genetics.
[27] A. Mukasa,et al. Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion , 2013, Stroke.
[28] E. Seo. Diagnosis and Treatment of Moyamoya Disease , 2013 .
[29] S. Nanayakkara,et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure , 2013, Environmental Health and Preventive Medicine.
[30] M. Guan,et al. Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population , 2012, PloS one.
[31] Iuliana Ionita-Laza,et al. Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets. , 2012, American journal of human genetics.
[32] Adam Kiezun,et al. Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.
[33] Y. Kuroiwa,et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease , 2012, Neurology.
[34] A. Fujiyama,et al. Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.
[35] A. Hata,et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.
[36] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[37] R. Scott,et al. Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.
[38] R. Deshaies,et al. RING domain E3 ubiquitin ligases. , 2009, Annual review of biochemistry.
[39] S. Kuroda,et al. Moyamoya disease: current concepts and future perspectives , 2008, The Lancet Neurology.
[40] S. Leal,et al. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.
[41] Narayanan Eswar,et al. Protein structure modeling with MODELLER. , 2008, Methods in molecular biology.
[42] K. Nozaki,et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[43] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[44] P. Freemont. Ubiquitination: RING for destruction? , 2000, Current Biology.